Cocrystal Pharma Inc. (COCP)
NASDAQ · Healthcare
Cocrystal Pharma Inc. Operating Income 2011–2020
Cocrystal Pharma Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Cocrystal Pharma Inc. operating income for the quarter ending March 31, 2026 was -2.4 M, a 20.14% increase year-over-year.
- Cocrystal Pharma Inc. operating income for the twelve months ending March 31, 2026 was -10.5 M, a 80.15% increase year-over-year.
- Cocrystal Pharma Inc. annual operating income for 2020 was -9.6 M, a 80.20% decrease from 2019.
- Cocrystal Pharma Inc. annual operating income for 2019 was -48.4 M, a 1145.33% increase from 2011.
- Cocrystal Pharma Inc. annual operating income for 2011 was -3.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cocrystal Pharma Inc. Operating Income — FAQ
Cocrystal Pharma Inc. (COCP) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Cocrystal Pharma Inc.'s operating income?
Cocrystal Pharma Inc. (COCP) reported operating income of -$10M for fiscal 2020.
Where can I see COCP's operating income history?
The chart and table above show Cocrystal Pharma Inc.'s operating income by year and by quarter, including the growth rate.